Skip to main content

Malignant Disease after Iodine-131 Therapy

  • Chapter
Anticarcinogenesis and Radiation Protection 2

Abstract

Iodine-131 therapy is one of the most common treatments for hyperthyroidism and thyroid cancer. Data on man exposed to 131-I are still scarce, and there is concern as to its possible genetic and carcinogenic effects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. E.L. Saenger, G.E. Thoma and E.A. Tompkins, Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-up Study. J. Am. Med. Assoc. 205:855–862 (1968).

    Article  CAS  Google Scholar 

  2. B.M. Dobyns, G.E. Sheline, J.B. Workman, E.A. Tompkins, W.M. McConahey, and D.V. Becker, Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the Cooperative Thyrotoxicosis Therapy Follow-up Study. J. Clin. Endocrinol. Metab. 38:976–998 (1974).

    Article  PubMed  CAS  Google Scholar 

  3. D.A. Hoffman, W.M. McConahey, J.F. Fraumeni Jr., and L.T. Kurland, Cancer incidence following treatment of hyperthyroidism. Int. J. Epidemiol. 11:218–224 (1982).

    Article  PubMed  CAS  Google Scholar 

  4. L.-E. Holm, Carcinogenic and genetic risks of ionizing radiation with special reference to radioiodines. In: Thyroid Diseases (C. Beckers, Ed.), pp 159–186 Pergamon Press, Paris, 1982.

    Google Scholar 

  5. H. Brincker, H.S. Hansen, and A.P. Andersen, Induction of leukemia by 131-I treatment of thyroid carcinoma. Br. J. Cancer 28:232–237 (1973).

    Article  PubMed  CAS  Google Scholar 

  6. C.J. Edmonds and T. Smith, The long-term hazards of the treatment of thyroid cancer with radioiodine. Br. J. Radiol 59:45–51 (1986).

    Article  PubMed  CAS  Google Scholar 

  7. L. Teppo, E. Pukkula, and E. Saxen, Multiple cancer -- an Epidemiologic Excersize in Finland. J. Natl. Cancer. Inst. 75:207–217 (1985).

    PubMed  CAS  Google Scholar 

  8. E. Ron and B. Modan, Thyroid and other neoplasms following childhood scalp irradiation. In: Radiation Carcinogenesis. Epidemiology and Biological Significance (J.D. Boice Jr. and J.F. Fraumeni Jr., Eds.), pp. 139–151 Raven Press, New York, 1984.

    Google Scholar 

  9. M.A. Tucker, J.D. Boice Jr., and D.A. Hoffman, Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935–82. Natl. Cancer Inst. Monogr. 68:161–189 (1985).

    PubMed  CAS  Google Scholar 

  10. A. Osterlind, J.H. Olsen, E. Lynge, and M. Ewertz, Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Denmark, 1943–80. Natl. Cancer Inst. Monogr. 68:361–368 (1985).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Holm, LE., Hall, P., Lundell, G. (1991). Malignant Disease after Iodine-131 Therapy. In: Nygaard, O.F., Upton, A.C. (eds) Anticarcinogenesis and Radiation Protection 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3850-9_31

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3850-9_31

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6718-5

  • Online ISBN: 978-1-4615-3850-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics